Articles avec mandats d'accès public - Paul C. BoutrosEn savoir plus
TotalIRSCOICRNIHPCCCCSGenome CanadaCancer Research UKCRSNGMRCWellcomeEuropean CommissionDoDAcademy of FinlandNHMRCNIHRNSFGovernment of SpainKWFHHMIVersus Arthritis, UKProstate Cancer UKCPRITFWOCanada First Research Excellence FundSwedish Research CouncilRCNBMBFFNSFRQSNSFCDFGBBSRCDFFBanking Foundation "la Caixa"NWODoris Duke Charitable FoundationNMRCAIRC Foundation for Cancer Research in ItalyRoyal Society UKCZIDOEVAASPRAHAARCFNRSFMCEMBLHelmholtzMTACSIRKnut and Alice Wallenberg FoundationAlzheimers's UKBHFEPSRCWHOARRSMSFHRGovernment of ItalyNCNBrain Tumour Charity, UKHealth Data Research, UKJSTMinistry of Health, Singapore
16 articles dont l'importation est refusée
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
KJ Kron, A Murison, S Zhou, V Huang, TN Yamaguchi, YJ Shiah, M Fraser, ...
Nature genetics 49 (9), 1336-1345, 2017
Exigences : Canadian Cancer Society, Instituts de recherche en santé du Canada, Prostate …
Auteurs responsables : M Lupien
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies
MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ...
European urology 72 (5), 665-674, 2017
Exigences : Canadian Cancer Society, Instituts de recherche en santé du Canada, Prostate …
Auteurs responsables : RG Bristow
The influence of BRCA2 mutation on localized prostate cancer
RA Taylor, M Fraser, RJ Rebello, PC Boutros, DG Murphy, RG Bristow, ...
Nature Reviews Urology 16 (5), 281-290, 2019
Exigences : National Health and Medical Research Council, Australia
Auteurs responsables : GP Risbridger
Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors
E Lalonde, R Alkallas, MLK Chua, M Fraser, S Haider, A Meng, J Zheng, ...
European urology 72 (1), 22-31, 2017
Exigences : Canadian Cancer Society, Instituts de recherche en santé du Canada, Prostate …
Auteurs responsables : E Lalonde
C-Terminal region of teneurin-1 co-localizes with dystroglycan and modulates cytoskeletal organization through an extracellular signal-regulated kinase-dependent stathmin-and …
D Chand, L Song, L Delannoy, D Barsyte-Lovejoy, S Ackloo, PC Boutros, ...
Neuroscience 219, 255-270, 2012
Exigences : Instituts de recherche en santé du Canada
Auteurs responsables : DA Lovejoy
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
R Mathur, Q Wang, PG Schupp, A Nikolic, S Hilz, C Hong, NR Grishanina, ...
Cell 187 (2), 446-463. e16, 2024
Exigences : Chan Zuckerberg Initiative
Auteurs responsables : JF Costello, F Yue
All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor …
HAJ Kim, PYF Zeng, MH Shaikh, N Mundi, F Ghasemi, E Di Gravio, ...
Oral Oncology 116, 105260, 2021
Exigences : US National Institutes of Health, Instituts de recherche en santé du Canada
Auteurs responsables : AC Nichols
Clonality of localized and metastatic prostate cancer
PC Boutros, M Fraser, T van der Kwast, RG Bristow
Current opinion in urology 26 (3), 219-224, 2016
Exigences : US National Institutes of Health, Canadian Cancer Society, Instituts de …
Auteurs responsables : RG Bristow
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
TM Ma, S Roy, X Wu, C Mantz, D Fuller, L Miszczyk, A Napieralska, ...
Radiotherapy and Oncology 166, 1-7, 2022
Exigences : US National Institutes of Health
Auteurs responsables : AU Kishan
Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer
MH Shaikh, A Dawson, SD Prokopec, JW Barrett, PYF Zeng, MI Khan, ...
Oral Oncology 146, 106580, 2023
Exigences : Instituts de recherche en santé du Canada
Auteurs responsables : AC Nichols
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
SA Patel, TM Ma, JK Wong, BJ Stish, RT Dess, A Pilar, C Reddy, ...
International Journal of Radiation Oncology* Biology* Physics 115 (3), 645-653, 2023
Exigences : US National Institutes of Health
Auteurs responsables : AU Kishan
A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways
AK Azad, I Bairati, X Qiu, H Girgis, L Cheng, D Waggott, D Cheng, ...
Cancer Epidemiology 42, 173-180, 2016
Exigences : Canadian Cancer Society, Instituts de recherche en santé du Canada
Auteurs responsables : G Liu
Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy–Resistant Early Breast Cancers
J Bayani, EN Kornaga, C Crozier, GH Jang, L Bathurst, I Kalatskaya, ...
JCO Precision Oncology 3, 1-13, 2019
Exigences : Instituts de recherche en santé du Canada, Ontario Institute for Cancer Research
Auteurs responsables : JMS Bartlett, J Bayani, LD Stein
Matching Kidneys and Urines: Establishing Noninvasive Surrogates of Intrarenal Events in Primary Glomerulonephritis
HN Reich, VY Sabelnykova, PC Boutros
Seminars in Nephrology 35 (3), 256-265, 2015
Exigences : Instituts de recherche en santé du Canada, Ontario Institute for Cancer Research
Auteurs responsables : HN Reich
PD05-03 Molecular hallmarks of mpmri visibility in prostate cancer
TY Sadun, KE Houlahan, A Salmasi, A Pooli, ER Felker, SS Raman, ...
Journal of Urology 201, e80-e81, 2019
Exigences : US National Institutes of Health
Auteurs responsables : RE Reiter
OP0091 A Low Density Granulocyte Gene Expression Signature Distinguishes Between Active Patients with and Without Nephritis in Systemic Lupus Erythematosus (SLE)
J Wither, S Prokopec, B Noamani, D Bonilla, Z Touma, H Reich, J Scholey, ...
Annals of the Rheumatic Diseases 74, 103, 2015
Exigences : Instituts de recherche en santé du Canada
Auteurs responsables : C Landolt-Marticorena
Disponibles quelque part : 326
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Cancer Genome Atlas Network
Nature 517 (7536), 576-582, 2015
Exigences : US National Institutes of Health
The repertoire of mutational signatures in human cancer
LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ...
Nature 578 (7793), 94-101, 2020
Exigences : US National Institutes of Health, Cancer Research UK, Wellcome Trust …
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R
H Chen, PC Boutros
BMC bioinformatics 12 (1), 1-7, 2011
Exigences : Instituts de recherche en santé du Canada, Ontario Institute for Cancer Research
Pan-cancer analysis of whole genomes
I The, TPCA of Whole, G Consortium
Nature 578 (7793), 82, 2020
Exigences : US National Institutes of Health, Cancer Research UK, UK Medical Research …
Les informations concernant la publication et le financement sont déterminées automatiquement par un programme informatique